Nabors Industries Ltd
NBR NYSE Drilling Oil & Gas Wells Financials FY2016–FY2025
Last close · Oct 23, 2026
$81.03
4.2%What Nabors Industries Ltd does
No business description yet.
- Legal name
- NABORS INDUSTRIES LTD
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 13, 2026
- Accession · CIK
- 0001104659-26-014997
0001163739
Revenue and margins
Nabors Industries Ltd had $3.2B of revenue in fiscal 2025, up 8.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$22.7M in fiscal 2025, −0.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Nabors Industries Ltd returned — to shareholders in fiscal 2025. The diluted share count rose 56.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Nabors Industries Ltd can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $991M | $452M | $1.1B | $397M | $941M |
| Debt incl. finance leases | $3.3B | $2.5B | $3.1B | $2.5B | $2.5B |
| Net debt / EBITDA | 3.7x | 2.9x | 1.9x | 2.0x | 1.4x |
| Debt / equity | 5.5x | 6.9x | 9.6x | 18.6x | 4.2x |
| Interest coverage | −0.5x | 0.2x | 2.3x | 2.0x | 2.2x |
| Current ratio | 2.9x | 1.7x | 1.4x | 1.7x | 1.6x |
| Quick ratio | 2.6x | 1.5x | 1.2x | 1.5x | 1.5x |
| Total assets | $5.5B | $4.7B | $5.3B | $4.5B | $4.8B |
| Total liabilities | $4.1B | $3.5B | $4.0B | $3.3B | $3.4B |
| Shareholders' equity | $591M | $369M | $327M | $135M | $591M |
| Net debt (− = net cash) | $2.3B | $2.1B | $2.1B | $2.1B | $1.6B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ |
| Current ratio rose | — | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | ✕ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | — | — |
| Revenue rose relative to assets | — | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ |
| F-score | — / 3 | 5 / 9 | 7 / 9 | 4 / 9 | 4 / 9 | 4 / 9 | 6 / 9 | 5 / 9 | 5 / 8 | 6 / 8 |
| Accruals ratio | −19.1% | −7.3% | −11.9% | −19.0% | −18.8% | −18.1% | −16.6% | −13.0% | −15.5% | −8.8% |
| Altman Z'' | 1.67 | 1.43 | 1.56 | 1.10 | 0.28 | 0.30 | −0.54 | 0.01 | −0.23 | 0.36 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.2B | $2.6B | $3.1B | $3.0B | $2.1B | $2.0B | $2.7B | $3.0B | $2.9B | $3.2B |
| Gross profit | $884M | $846M | $1.1B | $1.1B | $801M | $731M | $988M | $1.2B | — | — |
| Research and development | $33.6M | $51.1M | $56.1M | $50.4M | $33.6M | $35.2M | $49.9M | $56.3M | $57.1M | $53.1M |
| Operating income | −$118M | −$142M | $58.6M | $89.1M | −$171M | −$80.8M | $44.3M | $434M | $417M | $471M |
| Interest expense | $185M | $223M | $227M | $204M | $206M | $171M | $178M | $185M | $211M | $215M |
| Pretax income | −$1.2B | −$580M | −$519M | −$589M | −$706M | −$488M | −$246M | $129M | −$31.0M | $538M |
| Income tax | −$187M | −$83.0M | $79.3M | $91.6M | $57.3M | $55.6M | $61.5M | $79.2M | $56.9M | $163M |
| Net income | −$1.0B | −$547M | −$641M | −$703M | −$806M | −$569M | −$350M | −$11.8M | −$176M | $287M |
| Net income to common | −$1.0B | −$547M | −$653M | −$720M | −$820M | −$582M | −$361M | −$50.2M | −$206M | $247M |
| Diluted EPS | −$3.64 | −$1.90 | −$99.61 | −$105.39 | −$118.69 | −$76.58 | −$40.52 | −$5.49 | −$22.37 | $17.39 |
| Diluted shares | 0.28B | 0.28B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $532M | $62.8M | $326M | $685M | $350M | $429M | $501M | $638M | $581M | $693M |
| Capital expenditure | $395M | $574M | $459M | $428M | $196M | $234M | $373M | $541M | $568M | $716M |
| Free cash flow | $136M | −$512M | −$133M | $257M | $154M | $195M | $128M | $97.0M | $13.5M | −$22.7M |
| Depreciation and amortization | $872M | $843M | $867M | $876M | $854M | $693M | $665M | $645M | $633M | $649M |
| Stock-based compensation | $32.0M | $31.9M | $26.4M | $24.7M | $24.6M | $19.4M | $15.8M | $15.8M | $16.5M | $23.4M |
| Acquisitions | $22.3M | −$12.3M | $20.9M | $2.9M | — | — | — | — | — | — |
| Share buybacks | $1.7M | $18.1M | — | — | — | — | — | — | — | — |
| Dividends paid | $50.9M | $68.5M | — | — | $22.5M | $7.4M | $0.1M | $0.2M | $0.1M | — |
| Dividends and buybacks | $52.6M | $86.6M | — | — | $22.5M | $7.4M | $0.1M | $0.2M | $0.1M | — |
| Balance sheet | ||||||||||
| Cash and short-term investments | $295M | $365M | $482M | $452M | $482M | $991M | $452M | $1.1B | $397M | $941M |
| Total debt | $3.6B | $4.1B | $3.6B | $3.4B | $3.0B | $3.3B | $2.5B | $3.1B | $2.5B | $2.5B |
| Current assets | $1.2B | $1.4B | $1.6B | $1.2B | $1.1B | $1.5B | $1.0B | $1.6B | $1,000M | $1.6B |
| Current liabilities | $822M | $919M | $832M | $657M | $515M | $525M | $596M | $1.2B | $572M | $993M |
| Inventory | $104M | $166M | $166M | $176M | $161M | $126M | $128M | $148M | $130M | $94.8M |
| Property and equipment, net | $6.3B | $6.1B | $5.5B | $4.9B | $4.0B | $3.3B | $3.0B | $2.9B | $2.8B | $2.9B |
| Goodwill | $167M | $173M | $184M | $28.4M | — | — | — | — | — | — |
| Total assets | $8.2B | $8.4B | $7.9B | $6.8B | $5.5B | $5.5B | $4.7B | $5.3B | $4.5B | $4.8B |
| Total liabilities | $4.9B | $5.3B | $4.7B | $4.3B | $3.8B | $4.1B | $3.5B | $4.0B | $3.3B | $3.4B |
| Preferred stock | — | — | $0.0M | $0.0M | $0.0M | — | — | — | — | — |
| Shareholders' equity | $3.2B | $2.9B | $2.7B | $2.0B | $1.2B | $591M | $369M | $327M | $135M | $591M |
| Margins | ||||||||||
| Gross margin | 39.7% | 33.0% | 35.3% | 36.6% | 37.5% | 36.2% | 37.2% | 40.4% | — | — |
| Operating margin | −5.3% | −5.5% | 1.9% | 2.9% | −8.0% | −4.0% | 1.7% | 14.4% | 14.2% | 14.8% |
| EBITDA margin | 33.8% | 27.3% | 30.3% | 31.7% | 32.0% | 30.4% | 26.7% | 35.9% | 35.8% | 35.2% |
| Net margin | −46.2% | −21.3% | −21.0% | −23.1% | −37.8% | −28.2% | −13.2% | −0.4% | −6.0% | 9.0% |
| FCF margin | 6.1% | −20.0% | −4.4% | 8.4% | 7.2% | 9.7% | 4.8% | 3.2% | 0.5% | −0.7% |
| Returns | ||||||||||
| Return on capital | −1.4% | −1.7% | 0.8% | 1.4% | −3.7% | −2.2% | 1.4% | 11.8% | 14.7% | 15.3% |
| Return on capital employed | −1.6% | −1.9% | 0.8% | 1.5% | −3.4% | −1.6% | 1.1% | 10.7% | 10.6% | 12.4% |
| Return on equity | −31.7% | −17.8% | −22.8% | −30.0% | −51.4% | −65.4% | −73.0% | −3.4% | −76.3% | 79.0% |
| Return on assets | −12.6% | −6.6% | −7.9% | −9.6% | −13.1% | −10.3% | −6.8% | −0.2% | −3.6% | 6.2% |
| Return on tangible equity | −33.4% | −20.0% | −26.0% | −36.8% | −71.2% | −98.6% | −97.7% | −15.4% | −152.5% | 41.9% |
| Growth | ||||||||||
| Revenue growth | — | 15.1% | 19.2% | −0.5% | −29.9% | −5.5% | 31.5% | 13.3% | −2.5% | 8.7% |
| FCF growth | — | −475.0% | — | — | −39.9% | 26.3% | −34.5% | −24.0% | −86.1% | −267.9% |
| Share count change | — | 1.5% | −97.6% | 5.1% | 0.4% | 7.7% | 17.0% | 2.9% | 0.5% | 56.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.4x | 5.3x | 3.4x | 3.0x | 3.7x | 3.7x | 2.9x | 1.9x | 2.0x | 1.4x |
| Debt / equity | 1.1x | 1.4x | 1.3x | 1.7x | 2.6x | 5.5x | 6.9x | 9.6x | 18.6x | 4.2x |
| Interest coverage | −0.6x | −0.6x | 0.3x | 0.4x | −0.8x | −0.5x | 0.2x | 2.3x | 2.0x | 2.2x |
| Current ratio | 1.4x | 1.6x | 1.9x | 1.9x | 2.2x | 2.9x | 1.7x | 1.4x | 1.7x | 1.6x |
| Quick ratio | 1.3x | 1.4x | 1.7x | 1.6x | 1.9x | 2.6x | 1.5x | 1.2x | 1.5x | 1.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 17.8% | 22.4% | 15.0% | 14.1% | 9.2% | 11.6% | 14.1% | 18.0% | 19.4% | 22.5% |
| Stock comp / revenue | 1.4% | 1.2% | 0.9% | 0.8% | 1.2% | 1.0% | 0.6% | 0.5% | 0.6% | 0.7% |
| Payouts / FCF | 38.6% | — | — | — | 14.6% | 3.8% | 0.1% | 0.2% | 0.6% | — |
| Quality scores | ||||||||||
| Piotroski F-score | — | 5.0 | 7.0 | 4.0 | 4.0 | 4.0 | 6.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | 1.7 | 1.4 | 1.6 | 1.1 | 0.3 | 0.3 | −0.5 | 0.0 | −0.2 | 0.4 |
| Accruals ratio | −19.1% | −7.3% | −11.9% | −19.0% | −18.8% | −18.1% | −16.6% | −13.0% | −15.5% | −8.8% |
Source: SEC EDGAR XBRL filings (CIK 0001163739). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
